Skip to content
Research Article Open access CC BY 3.0

Urinary Excretion of Glycosaminoglycans in Patients with Urolithiasis

Seema Jawalekar, Vasant Surve, Anil Bhutey

International Journal of Biochemistry Research & Review · pp. 74–81 · Published 9 Mar 2013

10.9734/IJBCRR/2013/2850

Abstract

The interaction between tubular epithelial cells and calcium oxalate crystals or oxalate ions is a very precarious event in the lithogenesis. Urine contains ions, glycoproteins and glycosaminoglycans that inhibit the crystallization process and may protect the kidney against lithogenesis.  Hundred patients (24 women and 76 men) with a history of stone disease and hundred controls (25 women and 75 men) were evaluated for urinary GAG concentration. By using a new dye-binding assay, the total GAG concentration in the urine was measured and corrected to urinary creatinine levels (milligram of GAG per gram creatinine). There was a preponderance of urinary stones in males; the highest incidence being in Group 2. Excretion of GAGs in 24-hour urine sample was significantly lower in patients compared to controls, for males in all age groups and for females, however, there was no statistically significant difference in the urinary GAGs value between males and females in a given age group for either controls or patients. The urinary GAGs excretion idecreased with age in controls, but the levels in patients were lower. Conclusion: This study shows that low urinary GAGs are associated with urinary stones in patients. Our study lead us to propose that urinary GAG may play an important role in the prevention and reduction of calculi in patients with urolithiasis. Lower urinary GAG levels are more common in patients with stone formation. This may play a more determinant role in male patients and those with recurrent stone formation. We conclude that uric acid can constitute an important risk factor for calcium oxalate urolithiasis through heterogeneous nucleation and the GAGs can play an important role as preventive agents.

Calcium oxalate glycosaminoglycan uric acid

References (26)

  1. 1 Twenty-four–hour urine chemistries and the risk of kidney stones among women and men [DOI]
  2. 2 Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses. [DOI]
  3. 3 Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture [DOI]
  4. 4 Urine Volume: Stone Risk Factor and Preventive Measure [DOI]
  5. 5 Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer [DOI]
  6. 6 Identification of hyaluronan as a crystal-binding molecule at the surface of migrating and proliferating MDCK cells [DOI]
  7. 7 Crystal Retention in Renal Stone Disease [DOI]
  8. 8 Changes in cat urinary glycosaminoglycans with age and in feline urologic syndrome [DOI]
  9. 9 Characterization of glycosaminoglycans in tubular epithelial cells: Calcium oxalate and oxalate ions effects [DOI]
  10. 10 Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro [DOI]
  11. 11 Urinary excretion of glycosaminoglycans in normal and stone forming subjects [DOI]
  12. 12 Crystal inhibition: the effects of polyanions on calcium oxalate crystal growth [DOI]
  13. 13 Surface Interaction Between Glycosaminoglycans and Calcium Oxalate [DOI]
  14. 14 Possible role for chondroitin sulfate in urolithiasis: In vivo studies in an experimental model [DOI]
  15. 15 Uric Acid Urolithiasis and Crystallization Inhibitors [DOI]
  16. 16 Study of Factors Affecting Calcium Oxalate Crystalline Aggregation [DOI]
  17. 17 Glycosaminoglycans in Urolithiasis [DOI]
  18. 18 Comparative Study of 24-Hour Urinary Excretion of Glycosaminoglycans by Renal Stone Formers and Healthy Adults [DOI]
  19. 19 Specific isolation and analysis of mucopolysaccharides (glycosaminoglycans) from human urine [DOI]
  20. 20 Juvenile Renal Stone Disease: A Study of Urinary Promoting and Inhibiting Factors [DOI]
  21. 21 Urinary Glycosaminoglycan Excretion in Normal and Stone-Forming Subjects: Significant Disturbance in Recurrent Stone Formers [DOI]
  22. 22 THE EFFECT OF GLYCOSAMINOGLYCANS ON CALCIUM OXALATE CRYSTAL FORMATION [DOI]
  23. 23 Promoters and inhibitors of calcium urolithiasis in children.
  24. 24 Urinary excretion of glycosaminoglycans in normal individuals and patients with renal stones
  25. 25 Madin-Darby canine kidney cells are injured by exposure to oxalate and to calcium oxalate crystals [DOI]
  26. 26 Corrigendum [DOI]

Cited by 1

Computational Study of Nanosized Drug Delivery from Cyclodextrins, Crown Ethers and Hyaluronan in Pharmaceutical Formulations

Francisco Torrens, Gloria Castellano · Current Topics in Medicinal Chemistry · 2015

Related research

Article metrics

Real usage data collected on this platform.

71

Page views

0

PDF downloads

29

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.